• No results found

Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Electrolyte Disturbances—Implications for Anesthetic Management

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Electrolyte Disturbances—Implications for Anesthetic Management

... of hyperthermic intraperitoneal chemotherapy (HIPEC) is often associated with significant intraoperative electrolyte ...went HIPEC at our institution between December 2009 and January ...

5

Current practices of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies: an international survey of oncologic surgeons

Current practices of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies: an international survey of oncologic surgeons

... intraoperative hyperthermic intraperitoneal chemotherapy ...with HIPEC procedure, perioperative staging and surgery skill, assessment of residual tumors, and method used for ...

6

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei in a liver transplanted patient: a case report

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei in a liver transplanted patient: a case report

... Background: Diagnostic work-ups in transplanted immunosuppressed patients are a challenge as non-specific findings may be interpreted as transplant-related complications. If the disease in question is rare and slowly ...

5

View of Anaesthetic Management of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC): A True Challenge To an Anaesthetist
							| Journal of Current Medical Research and Opinion

View of Anaesthetic Management of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC): A True Challenge To an Anaesthetist | Journal of Current Medical Research and Opinion

... Patients diseased with gynecological malignancies were believed un- treatable with poor survival chances till hyperthermic intraperitoneal chemotherapy after capital cytoreductive surgery came into ...

6

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Advanced Ovarian Carcinoma: Initial Experience in Mexico

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Advanced Ovarian Carcinoma: Initial Experience in Mexico

... poor. Hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal metastases from epithelial ovarian cancer is a controversial ...and HIPEC plus systemic chemotherapy ...

5

The outcomes of isolated ureteral resection and reconstruction in non urologic cancer patients who underwent cytoreductive surgery (CRC) and hyperthermic intraperitoneal chemotherapy (HIPEC)

The outcomes of isolated ureteral resection and reconstruction in non urologic cancer patients who underwent cytoreductive surgery (CRC) and hyperthermic intraperitoneal chemotherapy (HIPEC)

... Peritoneal carcinomatosis is a disease characterized by peritoneal surface involvement of cancer cells. It is particularly seen in the late stages of gastrointestinal, gynecological cancers, and primary peritoneal malig- ...

7

Safety and preliminary results of perioperative chemotherapy and hyperthermic intraperitoneal chemotherapy (HIPEC) for high risk gastric cancer patients

Safety and preliminary results of perioperative chemotherapy and hyperthermic intraperitoneal chemotherapy (HIPEC) for high risk gastric cancer patients

... Our study demonstrated the preliminary results of a multimodality treatment protocol that involved the as- sociation of perioperative systemic and intraoperative hyperthermic chemotherapy with radical ...

7

Perioperative Management of Patients Undergonig Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Perioperative Management of Patients Undergonig Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

... Abstract Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy procedure have demonstrated their efficacy in treating patients with diffused peritoneal carcinomatosis. As a counterpart ...

6

Prophylactic effect of hyperthermic intraperitoneal chemotherapy in patients with high risk of developing peritoneal carcinomatosis from colorectal cancer

Prophylactic effect of hyperthermic intraperitoneal chemotherapy in patients with high risk of developing peritoneal carcinomatosis from colorectal cancer

... had HIPEC following radical surgery compared to those had surgery alone, It was noted that bowel regained its motility more rapid in surgery alone group than surgery plus ...

7

Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis

Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis

... iCRS/ HIPEC despite high-volume disease. CC scores from the initial CRS/HIPEC can also help identify patients for a repeat ...with HIPEC should be abandoned and an alternative approach pursued [31, ...

9

Clinical outcomes of complete cytoreduction with concurrent liver resection followed by hyperthermic intraperitoneal chemotherapy for synchronous peritoneal and liver metastatic colorectal cancer

Clinical outcomes of complete cytoreduction with concurrent liver resection followed by hyperthermic intraperitoneal chemotherapy for synchronous peritoneal and liver metastatic colorectal cancer

... or intraperitoneal organs was performed when the seeding tumor showed gross inva- ...ligation. HIPEC was performed using mitomycin C (35 mg/m 2 at 42–43 °C) mixed in 3 L of hypertonic solution (Dianeal®, ...

10

Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies

Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies

... of HIPEC to eradicate residual tumor nodules, micrometastases, and free cancer ...+ HIPEC for ...+ HIPEC group ...+ HIPEC be the standard treatment model for CRC PC patients ...+ HIPEC ...

12

The relationship between baseline nutritional status with subsequent parenteral nutrition and clinical outcomes in cancer patients undergoing hyperthermic intraperitoneal chemotherapy

The relationship between baseline nutritional status with subsequent parenteral nutrition and clinical outcomes in cancer patients undergoing hyperthermic intraperitoneal chemotherapy

... While there are no data available on the prevalence of malnutrition in patients with peritoneal carcinomatosis, malnutrition is observed in up to 67% of patients with ovarian cancer [12] and up to 80% of patients with ...

8

Cirrhosis is not a contraindication to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in highly selected patients

Cirrhosis is not a contraindication to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in highly selected patients

... We recommend extrapolating previous recommenda- tions for elective major surgery in cirrhotic patients to CRS/HIPEC. In the current study, all patients had a MELD score < 11, which has been shown in a large ...

7

Hepatectomy for metachronous colorectal liver metastases following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases: a report of three cases

Hepatectomy for metachronous colorectal liver metastases following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases: a report of three cases

... and HIPEC were performed 5 months after adjuvant chemo- ...adjuvant chemotherapy. Five months after CRS and HIPEC, liver metastasis to segment 6 was detected ...systemic chemotherapy (FOLFOX + ...

7

Neoadjuvant chemotherapy followed by fast-track cytoreductive surgery plus short-course hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced ovarian cancer: preliminary results of a promising all-in-one approach

Neoadjuvant chemotherapy followed by fast-track cytoreductive surgery plus short-course hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced ovarian cancer: preliminary results of a promising all-in-one approach

... the HIPEC phase, fresh- frozen plasma was administered (1 U/15 min), and diuresis was maintained at values ≥ 120 mL/15 min by optimization of the hemodynamic parameters and/or using a low dose of diuretics ...

10

Early results on the use of biomaterials as adjuvant to abdominal wall closure following cytoreduction and hyperthermic intraperitoneal chemotherapy

Early results on the use of biomaterials as adjuvant to abdominal wall closure following cytoreduction and hyperthermic intraperitoneal chemotherapy

... The authors would emphasize the limitations of this study. This series represents early results of an abdom- inal wall reconstructive technique that in our experience was found to be safe and effective in preventing ...

7

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal goblet cell carcinomas with peritoneal carcinomatosis: results from a single specialized center

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal goblet cell carcinomas with peritoneal carcinomatosis: results from a single specialized center

... of HIPEC for 40 min by using the open ...with intraperitoneal chemotherapeutic drugs administered at ...for HIPEC were mitomycin-C (12 mg/m 2 ) or 5-fluorouracil (5-FU; 300 mg/m 2 ) plus oxaliplatin ...

11

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

... Against this framework, it has to be emphasized that the technical feasibility and the efficacy of PIPAC are largely depending on the degree of enteroenteral and enteroparietal adhesions. In 12 % of our patients, abdom- ...

9

Role of laparoscopy in patients with peritoneal metastases considered for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)

Role of laparoscopy in patients with peritoneal metastases considered for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)

... + HIPEC are preoperative tumor bur- den measured in terms of the peritoneal carcinomatosis index (PCI) and completeness of cytoreduction (CC) ...+ HIPEC in which sur- gery achieved complete or near complete ...

7

Show all 4211 documents...

Related subjects